港股異動 | 阿里健康(0241.HK)升5% 創6個月新高
格隆匯11月21日丨阿里健康(0241.HK)今日明顯走強,現升4.88%創6個月新高,報8.59港元,暫成交1.8億港元,職責所在1032.9億港元。阿里巴巴香港公開發售已截止認購.市場消息透露,由於散户認購反應強勁,在港公開發售部分錄得超購逾40倍。公司作為阿里系的大健康板塊的代表,一定程度獲益阿里在港二次上市的市場效應。另外,新版《藥品管理法》呼之欲出,其中,允許有條件放開網售處方藥一條備受市場關注。業內人士認為,阿里健康、平安好醫生等醫藥電商平台將會受益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.